Arbutus Biopharma Corporation
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -4.77 | -100% |
| P/S |
|
21.68 | 33.76 | -35.77% |
|
|
| P/BV |
|
3.71 | 4.82 | -23.04% |
|
|
| P/FCF |
|
-3.97 | 61 | -106.51% |
|
|
| Ev/Ebitda |
|
-4.9 | -22.15 | -77.86% |
|
|
| Ev/S |
|
20.71 | 22.56 | -8.2% |
|
|
| Ev/FCF |
|
-4.32 | 68.78 | -106.28% |
|
|
| E/P |
|
-0.211 | 0.0178 | -1287.15% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-422.41 | 4.98 | -8587.41% | -703.28 | -39.94% |
| ROE |
|
-68.71 | 9.61 | -814.91% |
|
|
| ROA |
|
-50.45 | 0.3443 | -14754.38% |
|
|
| ROIC |
|
-123.8 | 7.63 | -1721.62% |
|
|
| ROS |
|
-401.57 | -25.17 | 1495.42% |
|
|
| ROCE |
|
-73.6 | 15.35 | -579.5% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1138 | -3.68 | -96.9% | -0.0722 | +57.71% |
| Nеt Debt/Ebitda |
|
0.2292 | -3.44 | -106.67% |
|
|
| Debt/Ratio |
|
0.0604 | 0.1985 | -69.57% |
|
|
| Debt/Equity |
|
1.71 | 1.66 | 2.87% |
|
|
| Debt/Net Income |
|
-0.1197 | 10.32 | -101.16% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5468 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.2632 | -100% | ||
| DSI |
|
0 | 0.2193 | -100% |
|
|
| Average dividend growth |
|
0 | 0.4414 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4968 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5468 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
202.35 | -56.89 | -455.69% | ||
| Growth impulse Ebitda in 5 years |
|
-20.77 | -54.68 | -62.02% | ||
| Growth impulse Net Income in 5 years |
|
-52.6 | -58.33 | -9.82% | ||
| Growth impulse FCF in 5 years |
|
21.43 | -49.48 | -143.31% | ||
| Growth impulse EPS in 5 years |
|
-83.68 | -32.41 | 158.19% |
IP Score
3.27/10
